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Background and purpose: Age related white matter changes (ARWMC) are frequent in non-demented old
subjects and are associated with impaired cognitive function. Our aim was to study the influence of vascular
risk factors and ARWMC on the neuropsychological performance of an independent elderly population, to
see if vascular risk factors impair cognition in addition to the effects of ARWMC.
Methods: Independent subjects, aged 65–84 years, with any degree of ARWMC were assessed using a
comprehensive neuropsychological battery including the Mini-Mental State Examination (MMSE), VADAS-
Cog (Alzheimer’s disease assessment scale) and the Stroop and Trail Making test. Vascular risk factors were
recorded and ARWMC (measured by MRI) were graded into three classes. The impact of vascular risk factors
and ARWMC on neuropsychological performance was assessed by linear regression analyses, with
adjustment for age and education.
Results: 638 patients (74.1 (5) years old, 55% women) were included. Patients with severe ARWMC
performed significantly worse on global tests of cognition, executive functions, speed and motor control,
attention, naming and visuoconstructional praxis. Diabetes interfered with tests of executive function,
attention, speed and motor control, memory and naming. Arterial hypertension and stroke influenced
executive functions and attention. The effect of these vascular risk factors was independent of the severity of
ARWMC, age and education.
Conclusion: ARWMC is related to worse performance in executive function, attention and speed. Diabetes,
hypertension and previous stroke influenced neuropsychological performance, independently of the severity
of ARWMC, stressing the need to control vascular risk factors in order to prevent cognitive decline in the
elderly.
C
erebral age related white matter changes (ARWMC) are
frequently described on brain imaging in demented and
non-demented elderly subjects.1 2 Some demographic and
vascular risk factors are associated with a higher risk of
developing ARWMC, with major emphasis on age, hyperten-
sion and stroke.3–6 On the other hand, recent epidemiological
evidence indicates that vascular risk factors play a role in the
development of cognitive impairment and dementia, including
degenerative dementia.7–11 ARWMC can be a mediator between
vascular risk factors and cognitive decline, while some
demographic characteristics can contribute towards protecting
cognitive function.12 Our aim was to study the influence of
ARWMC and vascular risk factors on the neuropsychological
performance of non-disabled independent elderly people with
ARWMC and to analyse if vascular risk factors had an
independent effect on cognitive performance.
METHODS
The LADIS (Leukoaraiosis and Disability) study is a prospective
multinational European project investigating the independent
impact of ARWMC on the transition to disability in the elderly.
The rationale, methodology and baseline assessment have been
described previously.12 13 Investigators were provided with a
specifically developed handbook with guidelines for applying
criteria and tools.13 In short, inclusion criteria for the study
were: (i) 65–84 years of age; (ii) changes in ARWMC on MRI of
any degree, according to the scale of Fazekas and colleagues14;
and (iii) no disability, as determined by the Instrumental
Activities of Daily Living scale.15 Patients were enrolled because
of minor neurological, cognitive or motor complaints, or
incidental findings on cranial imaging caused by non-specific
events, as detailed elsewhere.13 To assess vascular risk factors,
trained medical personnel used a structured and comprehen-
sive questionnaire together with review of the available records.
A detailed description of the study variables has been reported
previously.13 Those germane to this study are the vascular risk
factors.6 Vascular risk factor criteria have been described in
detail previously.6 Detailed criteria are given in appendix 1
(appendix 1 can be viewed on the J Neurol Neurosurg Psychiatry
website at http://www.jnnp.com/supplemental). In short, these
risk factors were: previous hypertension: current antihyperten-
sive treatment or blood pressure values >140/90 mm Hg in
subjects not taking antihypertensive medication, based on
multiple blood pressure measurements on several separate
occasions; diabetes mellitus: previous diagnosis and/or current
treatment with insulin or oral hypoglycaemic medications, or
an 8 h fasting plasma glucose level of >7.0 mmol/l or 126 mg/
dl; hyperlipidaemias: total cholesterol .200 mg/dl, low density
Abbreviations: ADAS, Alzheimer’s Disease Assessment Scale; ARWMC,
age related white matter changes; LADIS study, Leukoaraiosis and
Disability study; MMSE, Mini-Mental State Examination; TM, Trail Making
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lipoprotein .130 mg/dl, high density lipoprotein ,35 mg/dl
and triglyceride .200 mg/dl, on at least two occasions;
myocardial infarction; angina pectoris; heart failure; atrial
fibrillation; lower limb arteriopathy and peripheral vascular
disease; history of stroke and/or transient ischaemic attack;
cigarette smoking, expressed as smoked pack-years; alcohol
consumption, expressed as g/day consumed, with one drink
containing 10 g of alcohol. Subjects were classified as past
drinkers, not drinkers (never drinkers) and current drinkers
(subdivided into sporadic drinkers (,1 drink/week), low
drinkers (>1 drink/week but ,1 drink/day), moderate drinkers
(1–3 drinks/day) and heavy drinkers (.4 drinks/day)).
The degree of ARWMC severity was rated on FLAIR
sequences by central readers blind to the clinical data using
the three severity classes in the revised version of the visual
scale of Fazekas and colleagues.14 Medial temporal lobe atrophy
was assessed on coronal T1 weighted sequences using the MTA
scale.16
Neuropsychological assessment
The LADIS neuropsychological battery has been described in
detail elsewhere.12 The neuropsychological battery included the
Mini-Mental State Examination (MMSE)17 as a global measure
of cognitive function; the VADAS-Cog (Alzheimer’s Disease
Assessment Scale (ADAS-Cog) plus delayed recall, symbol digit,
digit span, mazes, digit cancellation and verbal fluency) as a
comprehensive instrument to assess orientation, language,
ideational and constructional praxis, immediate memory and
delayed recall)18; and the Stroop19 20 and Trail Making (TM)
test21 as measures of executive function. Tests were grouped by
cognitive domains, as follows: executive functions (Stroop,
verbal fluency and TM); attention (digit cancellation and
symbol digit test); speed and motor control (Trail A and time to
complete maze test); memory (digit span, word recognition,
word recall, delayed recall); language (commands and nam-
ing); praxis (visuoconstructional and ideational praxis; ADAS
subtests). To analyse performance by domain, a compound
measure for three main domains was calculated using standard
scores for individual tests, as described previously12: (1)
memory = z scores of (immediate word recall + delayed recall
+ word recognition + digit span)/4; (2) executive functions = z
scores of ((Stroop3-2) + (TMB-TMA) + symbol digit + verbal
fluency)/4; and (3) speed and motor control = z scores of
(TMA + mazes + digit cancellation)/3. Z scores of the tests that
had higher scores representing worse performance were
inverted (2Z) in order to calculate the compound measure
score.
Statistical analysis
Scores of neuropsychological tests were considered as contin-
uous variables. The influence of vascular risk factors and
severity of ARWMC (three grades) on neuropsychological
performance was analysed by t tests for variables with two
levels and one way ANOVAs for variables with more than two
levels. Adjustment of a for multiple comparisons was
performed with Bonferoni statistics. Alcohol intake effect was
analysed by dividing current by past and never drinkers. The
effect of the quantity of alcohol on neuropsychological
performance was analysed using one way ANOVA.
Linear regression analyses were performed to evaluate the
impact of vascular risk factors and ARWMC on scores for the
different cognitive domains and individual neuropsychological
tests. In the first model, we included vascular risk factors as
independent variables. In the second model, we added ARWMC
to determine if the effect of vascular risk factors in neuropsy-
chological tests was independent of the effect of ARWMC.
Linear regression analyses were adjusted for age, education,12
lacunes,22 medial temporal lobe atrophy and visual deficit. The
independent variables included in linear regression analyses
were selected from the bivariate analysis, with p,0.1 as the
screening criterion for selection of the variables. Infrequent
vascular risk factors (less than 5% frequency in the study
population) were excluded from linear regression analyses.
Data were analysed using SPSS 12.0 software.
RESULTS
From the 639 patients in the LADIS cohort, one patient was
excluded because of incomplete neuropsychological evaluation
and hence 638 patients were included in the present study.
Table 1 shows the patient characteristics and risk factors
relevant to the present study.
Influence of ARWMC severity on neuropsychological
evaluation
Analyses of variance (ANOVA) showed significant differences
in performance on the neuropsychological tests according to the
severity of ARWMC, most notably when comparing mild with
severe ARWMC (table 2). Patients with severe ARWMC
performed significantly worse on: (a) global measures of
cognition (MMSE and ADAS total score), (b) compound
measures of executive functions, speed and memory, (c) all
individual tests of the same domains, (d) attention and (e)
individual tests of memory, language and visuoconstructional
praxis.
Influence of vascular risk factors on neuropsychological
evaluation
T test results (data given in appendix 2; appendix 2 can be
viewed on the J Neurol Neurosurg Psychiatry website at http://
www.jnnp.com/supplemental) showed that patients with
hypertension performed significantly worse (p(0.001) on the
compound measure of executive functions, and on Stroop, TM
and symbol–digit tests. Patients with diabetes had worse
performance (p(0.001) on TM, symbol–digit test and immedi-
ate word recall tests. Patients with previous stroke had worse
performance (p(0.001) on the digit cancellation, symbol digit
tests and on the compound measure of executive functions.
Table 1 Baseline patient characteristics (n = 638)
Age (y) (mean (SD)) 74.1 (5)
Sex (F/M) 351 (55%)/287(45%)
Educational level (years of schooling) 9.6 (3.8)
Vascular risk factors (frequency)
Hypertension 445 (69.6%)
Diabetes mellitus 92 (14.4%)
Previous stroke 188 (29.4%)
Previous transient ischaemic attack 115 (18%)
Atrial fibrillation 49 (7.7%)
Angina pectoris 98 (15.3%)
Heart failure 21 (3.3%)
Myocardial infarction 72 (11.3%)
Cardiac valvulopathy 27 (4.2%)
Cardiac arrhythmias (other than atrial
fibrillation)
75 (11.7%)
Peripheral vascular disease 45 (7%)
Hypercholesterolaemia 315 (49.3%)
Hypertriglyceridaemia 96 (15%)
Alcohol consumption (current) 309 (48.4%)
Alcohol consumption (past) 41 (6.4%)
Smoking (current) 68 (10.7%)
Smoking (past) 224 (35.1%)
ARWMC
Mild 284 (44.5%)
Moderate 196 (30.7%)
Severe 158 (24.8%)
ARWMC, age related white matter changes.
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Current alcohol intake was associated with better performance
(p(0.001) on MMSE comparing past with never drinkers.
Linear regression analyses
Results of linear regression analyses to evaluate the impact of
ARWMC and vascular risk factors on neuropsychological
performance are shown in table 3. Results concerning global
measures of cognition and compound measures are also shown
in table 3. Results of regression analyses with individual tests
can be found in appendix 3 (appendix 3 can be viewed on the J
Neurol Neurosurg Psychiatry website at http://www.jnnp.com/
supplemental) (positive results are described in the text).
Linear regression analyses were repeated excluding stroke
patients (188 patients), and controlling for atrophy, lacunes22
and visual deficit (as potential confounders on the performance
of neuropsychological tests) and produced similar results (data
available on request).
Diabetes influenced the performance on the global measure
of cognition (ADAS total score), compound measures of
executive functions, speed and memory. Diabetes also influ-
enced tests of attention, language, praxis and some tests of
memory (word recall and delayed word recall). Arterial
hypertension was associated with worse performance on the
compound measure of executive functions, Trail B-A and
symbol digit tests. Stroke was associated with lower perfor-
mance on the compound measure of executive functions, on
Stroop test 3–2, and tests of attention (digit cancellation) and
memory (immediate word recognition). Patients with periph-
eral vascular disease performed significantly worse on global
measures (MMSE and ADAS total score), on the compound
measure of memory and on word recall test. Patients with
current alcohol intake had better performance on the MMSE,
on mazes, word recall and commands tests and on the
compound measure of speed, comparing never and past
drinkers. Patients with current alcohol intake were not
otherwise different on global status or other associated risk
factors. Using one way ANOVA to evaluate the impact of
alcohol quantity intake on neuropsychological performance,
moderate (1–3 drinks/day) and low drinkers (>1 drink/week
but ,1 drink/day) performed significantly better on the MMSE
than never drinkers (27.95 vs 26.99 (p,0.05) and 27.88 vs
26.99 (p,0.01)). No differences were found for severe drinkers.
Introducing ARWMC into the model, we found that it was
independently related to worse performance on global mea-
sures of cognition (MMSE and ADAS total score), compound
measures of executive functions and speed/motor control in all
tests of executive functions, attention, language (naming) and
visuoconstructional praxis. Education interfered with all
neuropsychological tests and the effect of age was retained.12
The presence of visual deficits and lacunes did not change the
impact of vascular risk factors on neuropsychological perfor-
mance.
DISCUSSION
This study confirmed that the severity of ARWMC is related to
worse performance on global measures of cognition, executive
functions, speed/motor control and tests of attention, naming
and visuoconstructional praxis. In previous studies, ARWMC
were associated with cognitive deficits in independent elderly
subjects, mainly in executive functions, attention, speed and
motor control23 24 but also with global measures of cogni-
tion,1 4 23 25 visuoconstructional1 23 and memory tasks.3 However,
the association was not consistent across all studies. We had
the opportunity to study the impact of ARWMC and simulta-
neously the impact of clinical vascular risk factors on
neuropsychological performance, controlling for demographic
variables and atrophy. We found that even controlling for the
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severity of ARWMC and atrophy, vascular risk factors (such as
diabetes, hypertension and previous stroke) emerged as
relevant variables with an influence on neuropsychological
tests. These results suggest that vascular risk factors impair
cognition, independent of cerebral damage measurable, using
current radiological methods. It is, however, conceivable that
other imaging methods (eg, diffusion tensor MRI) might have
demonstrated more extensive ARWMC and probably a less
independent effect of vascular risk factors.26
Our study has some limitations. The sample was selected
based on minor complaints, and probably represents the first
moment when non-disabled elderly people with cerebral white
mater changes seek medical attention. However, this sample
does not represent the global community. To increase consis-
tency and homogeneity in the whole assessment, investigators
were provided with a specifically developed handbook with
guidelines for applying criteria and tolls.13 The methodology
and inclusion criteria were uniform in all centres.13
Sociocultural and nutritional differences between countries
and consequent variation between vascular risk factors profile
in the included population may limit the external validity of the
results. However, the possible heterogeneity provided by
linguistic, cultural and educational differences of the LADIS
cohort makes the results more consistent and generalisable, as
they are from a large sample with a wide variety of subjects.
Moreover, validation and harmonisation of instruments and
procedures among centres, including the neuropsychological
battery, was done prior to the beginning of inclusion of
subjects, as discussed elsewhere.12 Differences across centres
were evaluated and could not explain the results.12 To exclude
Table 3 Impact of vascular risk factors on neuropsychological performance: cognitive
domains (linear regression analysis; global tests MMSE and ADAS total and compound
measures; executive functions; speed and motor control; and memory)
Cognitive measure Independent variables R square
R square
change F change b standard
MMSE
Model 1 0.16 0.16 17.16**
Model 2 Age 0.17 0.01 9.4** NS
Education 0.32**
Hypertension NS
Diabetes NS
PVD 20.08*
Cardiac arrhythmias NS
Current alcohol 0.13**
ARWMC 20.12**
ADAS total score
Model 1 0.14 0.14 20.59**
Model 2 Age 0.16 0.01 9.12** 0.15**
Education 20.27**
Hypertension NS
Diabetes 0.13**
PVD 0.11**
ARWMC 0.12**
Executive functions (compound measure)
Model 1 0.27 0.27 29.46**
Model 2 Age 0.29 0.02 15.58** 20.21**
Education 0.38**
Hypertension 20.38*
Previous stroke 20.1*
Diabetes 20.11**
PVD NS
Angina pectoris NS
ARWMC 0.15**
Speed and motor control (compound measure)
Model 1 0.19 0.19 20.5**
Model 2 Age 0.21 0.02 15.23** 20.16**
Education 0.34**
Hypertension NS
Previous stroke NS
Previous TIA NS
Diabetes 20.03**
Current alcohol 0.01*
ARWMC 20.15**
Memory (compound measure)
Model 1 0.13 0.13 12.57
Model 2 0.14 0.01 NS
Age 20.15**
Education 0.27**
Hypertension NS
Diabetes 20.11**
PVD 20.1*
Hypertriglyceridaemia NS
Current alcohol NS
ARWMC NS
ADAS, Alzheimer’s Disease Assessment Scale; ARWMC, age related white matter changes; MMSE, Mini-Mental State
Examination; PVD, peripheral vascular disease; TIA, transient ischaemic attack.
Results of b standard are presented only for model 2.
*p,0.05; **p,0.01.
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possible interference on the performance of neuropsychological
tests, visual deficits were considered in the regression analysis.
Recent evidence found that diabetics have a higher risk of
dementia, including Alzheimer’s disease,10 27 and that non-
demented diabetic patients performed worse on several
cognitive tasks compared with healthy controls.27 28 However,
in these studies, ARWMC was not taken into account. A recent
study found that patients with type 2 diabetes had a worse
performance on attention, executive functions, processing
speed and memory, which was associated with ARWMC.29 In
our study, diabetes was found to be the most important
vascular risk factor interfering with global tests, compound
measures of executive functions, speed/motor control and tests
of attention, memory, praxis and language. This association
was independent of the degree of ARWMC, atrophy, age,
education and presence of visual deficits.
Cognitive changes and higher risk of dementia have been
reported in patients with hypertension,8 9 30 and recent results
of trials using antihypertensive medication suggest a beneficial
effect on cognition.31 Van Swieten and colleagues30 also found
that patients with hypertension with confluent ARWMC
performed worse on tests of executive functions (TM and
Stroop), MMSE and the Wechsler Memory Scale visual subtest,
but not on other memory tests. Sierra et al found that middle-
aged hypertensive patients with ARWMC performed signifi-
cantly worse than hypertensive patients without ARWMC on
the digit span forward task.32 We found that hypertension was
associated with a worse performance on tests of attention and
mental flexibility, but not on other tests. One possible
explanation for the relatively modest impact of hypertension
may be related to the low proportion of non-hypertensive
subjects (only 30%) in the LADIS sample.
In a previous study, ARWMC was related to speed and
attention in stroke survivors,33 and stroke was proposed as a
mediator between cerebral small vessel disease and cognitive
decline.34 We found previous stroke to be associated with worse
performance on mental flexibility, attention and memory
recognition tests, independent of the severity of ARWMC.
The influence of alcohol intake on brain structure and
cognition is a controversial issue. Recent studies suggested that
light to moderate alcohol consumption is associated with a
reduced risk of dementia.35 Conversely, brain atrophy is
associated with alcohol intake, even for low intake drinkers,36
and controversial effects on ARWMC and infarcts were
reported. We found that mild and moderate drinkers performed
better on global evaluation (MMSE) than non-drinkers,
independent of education, age and ARWMC, but no other
association was found between alcohol intake and neuropsy-
chological testing, even when heavy drinkers were included.
These results could possibly reflect a ‘‘survival’’ bias.
In conclusion, the neuropsychological performance of inde-
pendent elderly subjects with ARWMC was influenced by
biological and demographic variables: severity of ARWMC,
some vascular risk factors, but also age and education12. These
results emphasise the key role of risk factor control for the
prevention of dementia and cognitive impairment.
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